Last reviewed · How we verify
Active c tactile fiber stimulation
At a glance
| Generic name | Active c tactile fiber stimulation |
|---|---|
| Sponsor | Soovu Labs Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Treating Stress and Anxiety in Individuals With Alcohol Use Disorder (AUD) (PHASE1)
- A New Method for Identifying Sensory Changes in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Active c tactile fiber stimulation CI brief — competitive landscape report
- Active c tactile fiber stimulation updates RSS · CI watch RSS
- Soovu Labs Inc. portfolio CI